Blog

PHARMAC is pleased to announce decisions relating to the listing of contrast media agents that will take effect from 1 ...

Novartis’ stomach tumour therapy Glivec (imatinib mesylate) is a giant leap closer to being funded by the NHS in England ...

Gilead Sciences has finally agreed a price of for its hepatitis C virus (HCV) therapy Sovaldi with Germany's main health ...

The German Institute for Quality and Efficiency in Health Care (IQWiG) has assessed documents subsequently submitted by the drug manufacturer ...

[:content [\3 \space \A \p \r \i \l \space \2 \0 \1 \4 \space \- \  \W \h \a \n \g \a \n \u \i \space \M \P \space \C \h \e \s \t \e \r \space \B \o \r \r \o \w \s \space \h \a \s \space \b \e \e \n \space \a \c \c \u \s \e \d \space \o \f \space \\ \" \m \i \s \l \e \a \d \i \n \g \\ \" \space \p \e \o \p \l \e \space \a \t \space \a \n \space \a \n \t \i \space \T \r \a \n \s \- \P \a \c \i \f \i \c \space \P \a \r \t \n \e \r \s \h \i \p \space \A \g \r \e \e \m \e \n \t \space \r \a \l \l \y " ..."]]

Two drug companies have attacked a decision to remove their treatments from a fund designed to give access to expensive ...

PHARMAC will change the way it makes funding decisions from late next year. ...

Thousands more cancer patients in England will be offered vital treatments in a £160m boost to the Cancer Drugs Fund (CDF), the ...

Patients are set to benefit from a significant drop in the price of many common drugs as a result of ...

PHARMAC is pleased to announce the award of Sole Subsidised Supply Status in the community, and Hospital Supply Status in ...

The list of drugs to be cut from the Cancer Drugs Fund has yet to be confirmed but drugmakers and ...

The draft Report from Stage 2 of the Review focussing on Insulin Pumps has now been published and is open for comment. ...

Drug spending authorities in England and Wales have clashed over whether a cannabis-based drug for treating pain in multiple sclerosis ...

Novartis Pharmaceuticals Canada Inc. is pleased to announce that Health Canada has issued a marketing authorization with conditions for Zykadia (ceritinib), a ...